The role of pharmacogenetics in cancer therapeutics

60Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

The variability in treatment responses and narrow therapeutic index of anticancer drugs are some of the key challenges oncologists face. The knowledge of pharmacogenetics can potentially aid in the discovery, development and ultimately individualization of anticancer drugs. The identification of genetic variations that predict for drug response is the first step towards the translation of pharmacogenetics into clinical practice. This review provides an update on the results of studies assessing the effects of germline polymorphisms and somatic mutations on therapeutic outcomes and highlights the potential applications and future challenges in pharmacogenetic research pertaining to cancer therapeutics. © 2006 The Authors.

References Powered by Scopus

A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase

5260Citations
N/AReaders
Get full text

A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?

1438Citations
N/AReaders
Get full text

The genetic basis of the reduced expression of bilirubin udp-glucuronosyltransferase 1 in gilbert's syndrome

1343Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Chronotherapy and the molecular clock: Clinical implications in oncology

139Citations
N/AReaders
Get full text

Clinical pharmacology and pharmacogenetics of gemcitabine

137Citations
N/AReaders
Get full text

Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: A meta-analysis in Caucasians

132Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yong, W. P., Innocenti, F., & Ratain, M. J. (2006, July). The role of pharmacogenetics in cancer therapeutics. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2006.02591.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

51%

Researcher 11

30%

Professor / Associate Prof. 7

19%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 17

36%

Medicine and Dentistry 13

28%

Pharmacology, Toxicology and Pharmaceut... 9

19%

Biochemistry, Genetics and Molecular Bi... 8

17%

Save time finding and organizing research with Mendeley

Sign up for free